BioSpace News Archive

Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.0 million and a loss per share of $0.50 for the second quarter of its 2021 fiscal year, the three months ended January 31, 2021 .

Sage Therapeutics Announces Continued Positive Zuranolone Data for Both 30 mg and 50 mg Doses in Open-Label SHORELINE Study in Patients with MDD

Independent Data Monitoring Committees endorse opening higher dose IMR-687 treatment arms in ongoing Ardent and Forte Phase 2b clinical trials after review of safety and tolerability data at lower doses

PRAX-114 Phase 2/3 clinical trial for treatment of MDD to initiate in March 2021 following IND clearance PRAX-944 Phase 2a high dose cohort topline data expected in mid-year 2021 Innovative collaboration with The Florey Institute expands pipeline via addition of 3 ASOs targeting rare epilepsies Cash Balance of $296.6M as of December 31, 2020 supports cash runway into 4Q22

Renowned Biotech Industry Innovator is Senior Partner at Flagship Pioneering, a member of Moderna Therapeutics’ Development Committee and former Chief Medical Officer of Merck

Seneca Biopharma, Inc. (Nasdaq: SNCA), today announced that leading independent proxy advisory firm Institutional Shareholder Services, Inc. (“ISS”) has recommended that Seneca stockholders vote in support of the proposed merger with Leading BioSciences, Inc.

Phase 2B clinical trial in patients with relapsed /refractory DLBCL expected to be initiated in Q2 2021 following guidance received from the FDA Maveropepimut-S (DPX-Survivac) in combination with Merck’s Keytruda ® (pembrolizumab) and low dose cyclophosphamide (CPA) shows promising preliminary results in two solid cancer indications in the basket trial

Prestigious honor validates potential of Alveo’s low-cost, accessible COVID-19 testing technology as company prepares for commercialization

Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces Completion of Its 20 th Pre-Clinical Study

Appili Therapeutics to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference on Friday, March 19 th